Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,136 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $454.94 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $260.24 | 6 | $0 (2024) |
| Abbott Laboratories | $142.64 | 2 | $0 (2024) |
| Novo Nordisk Inc | $67.10 | 5 | $0 (2024) |
| Mylan Specialty L.P. | $44.89 | 3 | $0 (2023) |
| Organon LLC | $35.68 | 4 | $0 (2022) |
| Lundbeck LLC | $34.84 | 2 | $0 (2024) |
| Lilly USA, LLC | $22.75 | 1 | $0 (2021) |
| Organogenesis Inc. | $19.41 | 1 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $378.69 | 13 | ABBVIE INC. ($163.74) |
| 2023 | $444.77 | 16 | Otsuka America Pharmaceutical, Inc. ($218.35) |
| 2022 | $54.52 | 3 | Organon LLC ($20.02) |
| 2021 | $258.41 | 18 | AbbVie Inc. ($141.39) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: PSYCHIATRY | ||||||
| 07/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $97.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $129.63 | General |
| Category: Diabetes Care | ||||||
| 01/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes Care | ||||||
| 11/29/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $87.75 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: PSYCHIATRY | ||||||
| 06/08/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $96.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/01/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 16 | $424.00 | $85.68 |
| 2022 | 6 | 110 | 126 | $29,394 | $5,952 |
| 2021 | 10 | 256 | 327 | $75,441 | $17,798 |
| 2020 | 10 | 241 | 293 | $74,553 | $16,289 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 14 | 16 | $424.00 | $85.68 | 20.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $8,126 | $1,838 | 22.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 31 | 32 | $9,148 | $1,664 | 18.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 22 | $5,156 | $1,184 | 23.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 12 | $3,093 | $587.63 | 19.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 19 | $3,312 | $554.16 | 16.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 20 | 22 | $560.24 | $124.94 | 22.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 48 | 50 | $20,916 | $5,065 | 24.2% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 28 | 30 | $11,888 | $3,065 | 25.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 37 | 37 | $10,226 | $2,015 | 19.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 28 | 30 | $7,294 | $1,634 | 22.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 29 | $6,620 | $1,585 | 23.9% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2021 | 18 | 21 | $4,748 | $1,154 | 24.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 24 | 39 | $6,506 | $1,112 | 17.1% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 11 | 30 | $3,154 | $992.10 | 31.5% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2021 | 13 | 13 | $2,890 | $881.66 | 30.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 31 | 48 | $1,199 | $294.40 | 24.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 36 | 38 | $15,374 | $4,062 | 26.4% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 31 | 33 | $12,508 | $3,470 | 27.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 33 | 34 | $8,903 | $1,885 | 21.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 23 | 53 | $8,471 | $1,623 | 19.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 27 | 27 | $6,264 | $1,505 | 24.0% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2020 | 15 | 16 | $3,414 | $1,049 | 30.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 19 | $4,094 | $968.97 | 23.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2020 | 16 | 17 | $3,660 | $947.04 | 25.9% |
About Dr. Brian Knowles, D.O
Dr. Brian Knowles, D.O is a Family Medicine healthcare provider based in Brookfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033212279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Knowles, D.O has received a total of $1,136 in payments from pharmaceutical and medical device companies, with $378.69 received in 2024. These payments were reported across 50 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,136).
As a Medicare-enrolled provider, Knowles has provided services to 621 Medicare beneficiaries, totaling 762 services with total Medicare billing of $40,125. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Brookfield, MO
- Active Since 09/06/2006
- Last Updated 08/09/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033212279
Products in Payments
- VRAYLAR (Drug) $454.94
- REXULTI (Drug) $295.08
- FREESTYLE LIBRE 3 (Device) $142.64
- Rybelsus (Drug) $41.38
- YUPELRI (Drug) $32.15
- Ozempic (Drug) $25.72
- EMGALITY (Drug) $22.75
- NEXPLANON (Drug) $20.02
- Puraply (Medical Supply) $19.41
- CAPLYTA (Drug) $16.09
- Nexplanon (Drug) $15.66
- (8829) Respiratoriy Care Undiv (Device) $13.80
- Yupelri (Drug) $12.74
- XARELTO (Drug) $12.26
- ELIQUIS (Drug) $11.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brookfield
Dr. Jeannie Kenkare, Do, DO
Family Medicine — Payments: $11,272
Shani Vaturi, Md, MD
Family Medicine — Payments: $4,703
Dr. Thomas Whelan, M.d, M.D
Family Medicine — Payments: $3,377
Darnella Gist, M.d, M.D
Family Medicine — Payments: $3,285
Priya Asija, Md, MD
Family Medicine — Payments: $1,871
Kenneth Pellegrino, M.d, M.D
Family Medicine — Payments: $997.11